Filing Details

Accession Number:
0001209191-22-059756
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 17:10:46
Reporting Period:
2022-11-30
Accepted Time:
2022-12-05 17:10:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1811063 Nuvation Bio Inc. NUVB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206977 E Kathryn Falberg C/O Nuvation Bio Inc.
1500 Broadway, Suite 1401
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-11-30 75,041 $1.85 75,041 No 4 P Indirect By Trust
Class A Common Stock Acquisiton 2022-12-01 84,959 $1.97 160,000 No 4 P Indirect By Trust
Class A Common Stock Acquisiton 2022-12-02 47,000 $1.98 207,000 No 4 P Indirect By Trust
Class A Common Stock Acquisiton 2022-12-05 43,000 $1.95 250,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Indirect By Trust
Footnotes
  1. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.805 to $1.90. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  2. Shares are held directly by The Falberg-Predovich Family Trust, of which the Reporting Person is Co-Trustee.
  3. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.92 to $1.99. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  4. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.925 to $2.00. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.